PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Tinospora sinensis is identified as one of 27 species effective in treating RA within the TTM system [PMID:36267280]. Tinosporine derived from the plant ameliorated joint damage and inflammation in collagen-induced arthritis rat models [PMID:40300353].
Stem extracts alleviated LPS-induced neuroinflammation in mice [PMID:39245241] and demonstrated neuroprotective capabilities against rotenone-induced motor impairments and oxidative stress in rat models [PMID:42287110].
Tinospora sinensis was evaluated for hepatoprotective potential against alcohol-induced hepatotoxicity in rats [PMID:28646813].
Alkaloid-rich extracts from the root induced death in HCT-116 colon cancer cells via ROS-mediated, mTOR-dependent apoptosis [PMID:36737760].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 36400639 (2023) — Can Guduchi (Tinospora cordifolia), a well-known ayurvedic hepato-protectant cause liver damage? · Journal of Ayurveda and integrative medicine
- 2.PMID: 36267280 (2022) — Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis. · Frontiers in pharmacology
- 3.PMID: 38546704 (2024) — A Review on Traditional Uses, Phytochemistry, Pharmacology and Clinical Application of Tinospora sinensis (Lour.) Merr. · Chemistry & biodiversity
- 4.PMID: 39245241 (2025) — Extract of Tinospora sinensis alleviates LPS-induced neuroinflammation in mice by regulating TLR4/NF-κB/NLRP3 signaling pathway. · Journal of ethnopharmacology
- 5.PMID: 35245632 (2022) — Probing PXR activation and modulation of CYP3A4 by Tinospora crispa and Tinospora sinensis.